BRPI0917518A2 - formulações de canfosfamida e suas preparações - Google Patents

formulações de canfosfamida e suas preparações

Info

Publication number: BRPI0917518A2
Authority: BR; Brazil
Prior art keywords: camphosphamide; formulations; preparations therefor; therefor; preparations
Prior art date: 2008-08-28

Application number

BRPI0917518A

Other languages

English (en)

Inventor

Betsy R Hughes

Original Assignee

Telik Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-28

Filing date

2009-08-04

Publication date

2015-11-17

2009-08-04 Application filed by Telik Inc filed Critical Telik Inc

2015-11-17 Publication of BRPI0917518A2 publication Critical patent/BRPI0917518A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0917518A 2008-08-28 2009-08-04 formulações de canfosfamida e suas preparações BRPI0917518A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9258008P	2008-08-28	2008-08-28
PCT/US2009/052694 WO2010025011A1 (en)	2008-08-28	2009-08-04	Formulations of canfosfamide and their preparation

Publications (1)

Publication Number	Publication Date
BRPI0917518A2 true BRPI0917518A2 (pt)	2015-11-17

Family

ID=41168726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0917518A BRPI0917518A2 (pt)	2008-08-28	2009-08-04	formulações de canfosfamida e suas preparações

Country Status (17)

Country	Link
US (2)	US20100056825A1 (pt)
EP (1)	EP2328591A1 (pt)
JP (1)	JP2012501331A (pt)
KR (1)	KR20110060898A (pt)
CN (1)	CN102123714A (pt)
AR (1)	AR073074A1 (pt)
AU (1)	AU2009286010A1 (pt)
BR (1)	BRPI0917518A2 (pt)
CA (1)	CA2733548A1 (pt)
CL (1)	CL2011000439A1 (pt)
IL (1)	IL211039A0 (pt)
MX (1)	MX2011001867A (pt)
NZ (1)	NZ591213A (pt)
RU (1)	RU2011109921A (pt)
TW (1)	TW201008599A (pt)
WO (1)	WO2010025011A1 (pt)
ZA (1)	ZA201101214B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100056825A1 (en)	2008-08-28	2010-03-04	Telik, Inc.	Formulations of canfosfamide and their preparation
US8324426B2 (en)	2008-08-28	2012-12-04	Telik, Inc.	Formulations of canfosfamide and their preparation
WO2012115655A1 (en) *	2011-02-25	2012-08-30	Telik, Inc.	Formulations of canfosfamide and their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4931441A (en)	1988-11-09	1990-06-05	Luitpold Pharmaceuticals, Inc.	Stabilized aqueous leucovorin calcium compositions
US6403098B1 (en)	1996-09-26	2002-06-11	Merck & Co., Inc.	Rotavirus vaccine formulations
ATE244560T1 (de)	1999-03-19	2003-07-15	Ranbaxy Lab Ltd	Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil
US20060286037A1 (en)	2003-08-08	2006-12-21	Ono Pharmaceutical Co., Ltd.	Heart-slowing drug containing short-acting ß blocker as the active ingredient
US8198247B2 (en) *	2004-12-21	2012-06-12	Telik, Inc.	Process for and intermediates in the preparation of canfosfamide and its salts
AU2006284657B2 (en)	2005-08-31	2012-07-19	Abraxis Bioscience, Llc	Compositions and methods for preparation of poorly water soluble drugs with increased stability
US20100056825A1 (en)	2008-08-28	2010-03-04	Telik, Inc.	Formulations of canfosfamide and their preparation
US8324426B2 (en)	2008-08-28	2012-12-04	Telik, Inc.	Formulations of canfosfamide and their preparation

2009
- 2009-07-29 US US12/511,245 patent/US20100056825A1/en not_active Abandoned
- 2009-08-04 BR BRPI0917518A patent/BRPI0917518A2/pt not_active IP Right Cessation
- 2009-08-04 KR KR1020117006106A patent/KR20110060898A/ko not_active Application Discontinuation
- 2009-08-04 CA CA2733548A patent/CA2733548A1/en not_active Abandoned
- 2009-08-04 WO PCT/US2009/052694 patent/WO2010025011A1/en active Application Filing
- 2009-08-04 CN CN2009801320358A patent/CN102123714A/zh active Pending
- 2009-08-04 NZ NZ591213A patent/NZ591213A/xx not_active IP Right Cessation
- 2009-08-04 EP EP09791143A patent/EP2328591A1/en not_active Withdrawn
- 2009-08-04 JP JP2011525064A patent/JP2012501331A/ja active Pending
- 2009-08-04 AU AU2009286010A patent/AU2009286010A1/en not_active Abandoned
- 2009-08-04 MX MX2011001867A patent/MX2011001867A/es not_active Application Discontinuation
- 2009-08-04 RU RU2011109921/15A patent/RU2011109921A/ru unknown
- 2009-08-06 TW TW098126465A patent/TW201008599A/zh unknown
- 2009-08-18 AR ARP090103165A patent/AR073074A1/es not_active Application Discontinuation
2011
- 2011-02-03 IL IL211039A patent/IL211039A0/en unknown
- 2011-02-15 ZA ZA2011/01214A patent/ZA201101214B/en unknown
- 2011-02-28 CL CL2011000439A patent/CL2011000439A1/es unknown
- 2011-03-22 US US13/069,239 patent/US8481781B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2010025011A8 (en)	2010-09-30
MX2011001867A (es)	2011-04-07
WO2010025011A1 (en)	2010-03-04
IL211039A0 (en)	2011-04-28
TW201008599A (en)	2010-03-01
AU2009286010A1 (en)	2010-03-04
CN102123714A (zh)	2011-07-13
RU2011109921A (ru)	2012-10-10
NZ591213A (en)	2012-11-30
CL2011000439A1 (es)	2011-07-15
US8481781B2 (en)	2013-07-09
CA2733548A1 (en)	2010-03-04
JP2012501331A (ja)	2012-01-19
US20110224175A1 (en)	2011-09-15
AR073074A1 (es)	2010-10-13
US20100056825A1 (en)	2010-03-04
ZA201101214B (en)	2013-07-31
KR20110060898A (ko)	2011-06-08
EP2328591A1 (en)	2011-06-08

Publication	Publication Date	Title
BRPI0914155A2 (pt)	2015-10-20	preparações de xampu
DK2068886T3 (da)	2013-11-18	Lipidholdige præparater
BRPI0912213A2 (pt)	2015-10-06	preparação cosmética
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
BRPI0814252A2 (pt)	2015-04-14	Formulações de anticorpo
BRPI0908785A2 (pt)	2015-07-28	Formulações herbicida
BRPI0814003A2 (pt)	2015-02-03	Formulações de anticorpo
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0919552A2 (pt)	2015-08-18	Formulações de glifosato contendo surfactantes e amidoalquilamina
BRPI1012533A2 (pt)	2015-09-22	composto de piradazinona e uso do mesmo
DK2066354T3 (da)	2013-05-27	Norovirus vaccine formuleringer
BRPI0914152A2 (pt)	2015-10-20	preparações de xampu
BRPI0909770A2 (pt)	2015-08-11	Vacina, e, kit
BRPI0814188A2 (pt)	2014-10-14	Formulações
BRPI0822221A2 (pt)	2015-06-23	Composições aquosas e estáveis de ciclosporina
BR112012005389A2 (pt)	2015-09-08	preparações pesticidas
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
BRPI0921947A2 (pt)	2018-10-16	formulações de proteína terapêutica
DE112008003934A5 (de)	2011-04-07	Kosmetikmaske
BRPI0908455A2 (pt)	2015-12-15	formulações de flibanserina
BRPI0910570A2 (pt)	2015-09-22	uso de bioconjugados, e, formulações farmacêuticas
BRPI1008147A2 (pt)	2016-03-08	composição de xampu concentrado e xampu centrado
ATE520307T1 (de)	2011-09-15	Stabilisierte malathion-mikrokapselformulierungen
FR2915896B1 (fr)	2011-05-27	Composition cosmetique foisonnee
BRPI0823402A2 (pt)	2015-06-16	Formulações farmacêuticas de olmesartan

Legal Events

Date	Code	Title	Description
2016-06-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-09-27	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.